Offc Action Outgoing

BIOSTAR

BioSTAR Medical, LLC

U.S. Trademark Application Serial No. 88889294 - BIOSTAR - 206380608832

To: BioSTAR Medical, LLC (dockets@riversidelaw.com)
Subject: U.S. Trademark Application Serial No. 88889294 - BIOSTAR - 206380608832
Sent: July 22, 2020 10:20:53 AM
Sent As: ecom107@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

U.S. Application Serial No. 88889294

 

Mark:  BIOSTAR

 

 

 

 

Correspondence Address: 

RYAN D. ARTIS

RIVERSIDE LAW LLP

GLENHARDIE CORPORATE CENTER

1285 DRUMMERS LANE, SUITE 202

WAYNE, PA 19087

 

 

Applicant:  BioSTAR Medical, LLC

 

 

 

Reference/Docket No. 206380608832

 

Correspondence Email Address: 

 dockets@riversidelaw.com

 

 

 

NONFINAL OFFICE ACTION

 

The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned.  Respond using the Trademark Electronic Application System (TEAS).  A link to the appropriate TEAS response form appears at the end of this Office action. 

 

 

Issue date:  July 22, 2020

 

The referenced application has been reviewed by the assigned trademark examining attorney.  Applicant must respond timely and completely to the issue(s) below.  15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.

 

No Conflicting Marks Noted

 

The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d).  15 U.S.C. §1052(d); TMEP §704.02.

 

Incorrect Classification of Goods

 

Applicant has classified the following goods and services in International Class 42:  “Human allograft tissue; Biological tissue grafts; Biological tissue, namely, human tissue for use in scientific and medical research; Biological human tissue intended for subsequent implantation; Biological implants, namely, a vital processed human or animal connective tissue; Biological tissue, namely, liquid placental connective tissue for wound care and treating inflammatory conditions; Human tissue bank services.”  However, the proper classification for each item is as follows:  Class 1: Biological tissue, namely, human tissue for use in scientific and medical research; Class 5: Human allograft tissue; Biological tissue grafts; Biological human tissue intended for subsequent implantation; Biological implants, namely, a vital processed human or animal connective tissue; Biological tissue, namely, liquid placental connective tissue for wound care and treating inflammatory conditions; Class 44: Human tissue bank services. 

 

Additionally, applicant has provided the application fee for only 1 international class.  Thus, not all international classes in the application are covered by the application fee.  Because of this disparity, applicant must clarify the number of classes for which registration is sought.  See 37 C.F.R. §§2.32(d), 2.86.

 

Applicant may respond by (1) adding one or more international class(es) to the application, and reclassifying the above goods and/or services accordingly; or (2) deleting from the application the goods and/or services for all but the number of international class(es) for which the application fee was submitted.  See 37 C.F.R. §§2.86(a), 6.1; TMEP §§1403.02 et seq.  If applicant adds one or more international classes to the application, applicant must satisfy all the requirements below for each international class based on Trademark Act Section 1(b):

 

(1)        List the goods and/or services by their international class number in consecutive numerical order, starting with the lowest numbered class.

 

(2)        Submit a filing fee for each international class not covered by the fee(s) already paid (view the USPTO’s current fee schedule).  The application identifies goods and/or services that are classified in at least 4 classes; however, applicant submitted a fee sufficient for only 1 class.  Applicant must either submit the filing fees for the classes not covered by the submitted fees or restrict the application to the number of classes covered by the fees already paid.

 

See 37 C.F.R. §2.86(a); TMEP §§1403.01, 1403.02(c).

 

For an overview of the requirements for a Section 1(b) multiple-class application and how to satisfy the requirements online using the Trademark Electronic Application System (TEAS) form, see the Multiple-class Application webpage.

 

 

 

 

How to respond.  Click to file a response to this nonfinal Office action.    

 

 

/Michael Engel/

Trademark Examining Attorney

Law Office 107

Michael.Engel@uspto.gov

(571) 272-9338

 

 

 

 

 

RESPONSE GUIDANCE

  • Missing the response deadline to this letter will cause the application to abandon.  A response or notice of appeal must be received by the USPTO before midnight Eastern Time of the last day of the response period.  TEAS and ESTTA maintenance or unforeseen circumstances could affect an applicant’s ability to timely respond.  

 

 

 

U.S. Trademark Application Serial No. 88889294 - BIOSTAR - 206380608832

To: BioSTAR Medical, LLC (dockets@riversidelaw.com)
Subject: U.S. Trademark Application Serial No. 88889294 - BIOSTAR - 206380608832
Sent: July 22, 2020 10:20:53 AM
Sent As: ecom107@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

 

USPTO OFFICIAL NOTICE

 

Office Action (Official Letter) has issued

on July 22, 2020 for

U.S. Trademark Application Serial No. 88889294

 

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter that you must respond to by the specified deadline or your application will be abandoned.  Please follow the steps below.

 

(1)  Read the official letter.

 

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

 

 

Engel, Michael

/Michael Engel/

Trademark Examining Attorney

Law Office 107

Michael.Engel@uspto.gov

(571) 272-9338

 

 

 

 

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

 

(3)  Respond within 6 months (or earlier, if required in the Office action) from July 22, 2020, using the Trademark Electronic Application System (TEAS).  The response must be received by the USPTO before midnight Eastern Time of the last day of the response period.  See the Office action for more information about how to respond

 

 

 

GENERAL GUIDANCE

·         Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

 

·         Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

 

·         Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”

 

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed